Press release
Biomarkers Market Greater Revenue Share by 2020
Biomarkers are molecular or cellular diagnostic tools, measured in biological samples such as blood, saliva and urine. It is used as an indicator to measure and evaluate biological processes, pharmacological response and pathogenic processes. Some of the major types of biomarkers are prognostic, predictive, pharmacodynamic and efficacy response biomarker. A variety of biomarkers are available for biological systems such as immune system, cardiovascular system and metabolic system.Biomarkers are used to detect, predict disease susceptibility and monitor disease progression for infectious diseases, cancer, metabolic diseases, central nervous system disease and autoimmune diseases. Biomarker technologies have its applications in diagnosis and prognostic treatment for exposure of harmful chemicals, drug formulation and development and increasing implementation in disease diagnosis.
Many drugs fail in clinical trials due to metabolism, toxicity, absorption, etc. Biomarkers are special tools usually used in clinical studies to determine the effects and desired results of drug in early stages of development. Biomarkers are cost effective and reliable for developing, monitoring and predicting efficiency of drugs.
North America dominates the global market of biomarkers due to increasing demand of aging population for diagnosis and treatment of age related diseases. In addition, higher adoption rate of biomarkers technologies is also driving the growth of biomarkers market in North America. Asia is expected to show high growth rates in the next five years in global biomarkers market. Some of the factors driving the growth of biomarkers market in emerging markets of Asia are increasing research and development activity in India and China, increasing number of contract research organizations and low cost for conducting clinical trials.
In recent times there is increased use of biomarkers due to increase in prevalence of various diseases. FDA support for biomarkers development and increasing demand of personalized medicine are some of the factors driving the growth for global biomarkers market. In addition, usage of biomarkers by large scale pharmaceuticals manufacturing companies to overcome increasing failure rates for drugs in clinical trial phase II and III, and increasing drug development cost are also fueling the growth for global biomarkers market. However, high cost of validation and high capital investment required for the application, discovery and development of biomarkers are some of the factors restraining the growth for global biomarkers market.
Growing importance of companion diagnostics and increasing demand of personalized medicine are some of the opportunities for global biomarkers market. However, ethical and regulatory issues, and early and accurate diagnosis for fatal diseases are some of the challenges for global biomarkers market. Government grants and initiatives for research and development of biomarkers are some of the trends for global biomarkers market. Some of the major companies operating in the global biomarkers market are Roche Diagnostic Limited, Siemens Healthcare, Abbott Laboratories Inc., Thermo Fisher Scientific, Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Aushon BioSystem Inc., Epistem Ltd, G.E. Healthcare Inc., and Affymetrix, Inc.
Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/2779
Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/2779
Key points covered in the report
Report segments the market on the basis of types, application, products, technology, etc (as applicable)
The report covers geographic segmentation
North America
Europe
Asia
RoW
The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020
The report provides company profiles of some of the leading companies operating in the market
The report also provides porters five forces analysis of the market.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
Telephone - +1-646-568-7751
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biomarkers Market Greater Revenue Share by 2020 here
News-ID: 1020586 • Views: …
More Releases from Persistance Market Research

DNA/RNA Extraction Machine Market to Grow at 7.2% CAGR Through 2031, Says Persis …
The global DNA/RNA extraction machine market is poised for significant expansion, fueled by the rise of molecular diagnostics, the genomics boom, and increasing investments in biomedical research. These machines serve a critical role in isolating and purifying nucleic acids from various biological samples, forming the foundation for downstream applications like PCR, sequencing, and diagnostics.
In 2024, the DNA/RNA extraction machine market is estimated at US$1.4 billion, with forecasts projecting growth…

Quinoa Market Set to Hit US$2.3 Bn by 2031, Riding a Strong 9.8% CAGR
The global quinoa market is poised for remarkable growth in the coming years, with projections estimating a market value of US$2.3 billion by 2031, up from US$1.2 billion in 2024. Driven by increasing consumer demand for nutritious and organic food options, the market is expected to register a CAGR of 9.8% between 2024 and 2031, According to Persistence Market Research.
Request a sample report@ https://www.persistencemarketresearch.com/samples/34798
Key Market Drivers
One of the key drivers…

Evolving Trends in the Insulin Pens Market: A Comprehensive Report
Market Overview:
The Insulin Pens Market has witnessed remarkable growth and innovation over the years. Insulin pens are medical devices used by individuals with diabetes to administer insulin easily and accurately. These devices have become an integral part of diabetes management, offering numerous advantages over traditional insulin delivery methods, such as syringes and vials.
In 2022, the global market for insulin pens brought in US$ 16.2 billion in revenue and is predicted…
Smart Machines Market to register growth at a CAGR of 20.1% throughout 2023-2033
The market for smart machines was valued at US$ 73,456.2 Mn in 2022, and it is expected to grow to US$ 5,44,986.6 Mn by the end of 2033. In 2023, the market for smart machines is expected to be worth US$ 87,045.6 Mn. From 2023 to 2033, the market for Smart Machines is expected to grow at a CAGR of 20.1%.
The market for artificially intelligent machines and systems that can…
More Releases for Biomarker
Transformative Trends Impacting the Multiplex Biomarker Imaging Market Landscape …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Multiplex Biomarker Imaging Market Size By 2025?
In recent times, the size of the multiplex biomarker imaging market has experienced significant growth. There is an expected rise from $0.49 billion in 2024 to $0.54 billion in 2025, with a compound annual growth rate (CAGR) of…
Biomarker Discovery Outsourcing Services Market Biomarker Discovery Outsourcing: …
Biomarker Discovery Outsourcing Services Market to reach over USD 52.82 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers And Surrogate Endpoints),
Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases), Discovery Phase (Biomarker Identification, Biomarker Validation,…
Biomarker and Companion Diagnostics Conference | Modeling Strategies for Biomark …
MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Boston, USA.
Register Now @ https://events.marketsandmarkets.com/2nd-annual-biomarker-and-companion-diagnostics-conference-usa-edition/register
MarketsandMarkets 5th Annual Biomarker and Companion Diagnostics Conference:
Immerse yourself in the realm of biomarkers at our flagship event, where industry leaders and experts converge to propel innovation in healthcare, diagnostics, and personalized medicine. This conference serves as a dynamic platform for collaboration, knowledge sharing, and exploration of cutting-edge…
Biomarker Testing Market | Agilent Technologies, Roche, ,
The global biomarker testing market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the biomarker testing market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth of the…
Central Nervous System (CNS) Biomarkers Market Analysis Forecast 2023-2028 Globa …
The Central Nervous System (CNS) biomarkers market refers to the market for biomarkers used in the diagnosis, prognosis, and monitoring of diseases and disorders affecting the central nervous system. The central nervous system includes the brain and spinal cord, and disorders affecting this system can have significant impacts on an individual's health and well-being.
CNS biomarkers are measurable indicators that can provide information about the state of the central nervous system,…
Multiplex Biomarker Imaging Market - Advanced Solutions for Comprehensive Biomar …
Newark, New Castle, USA: The "Multiplex Biomarker Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Multiplex Biomarker Imaging Market: https://www.growthplusreports.com/report/multiplex-biomarker-imaging-market/8558
This latest report researches the industry structure,…